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Structural model of human 
dUTPase in complex with a novel 
proteinaceous inhibitor
Kinga Nyíri1,2, Haydyn D. T. Mertens  3, Borbála Tihanyi2, Gergely N. Nagy1,2,6,  
Bianka Kőhegyi1, Judit Matejka1, Matthew J. Harris4, Judit E. Szabó1,2, Veronika Papp-Kádár1,2, 
Veronika Németh-Pongrácz2, Olivér Ozohanics  5, Károly Vékey5, Dmitri I. Svergun3,  
Antoni J. Borysik4 & Beáta G. Vértessy1,2
Human deoxyuridine 5′-triphosphate nucleotidohydrolase (dUTPase), essential for DNA integrity, acts 
as a survival factor for tumor cells and is a target for cancer chemotherapy. Here we report that the 
Staphylococcal repressor protein StlSaPIBov1 (Stl) forms strong complex with human dUTPase. Functional 
analysis reveals that this interaction results in significant reduction of both dUTPase enzymatic activity 
and DNA binding capability of Stl. We conducted structural studies to understand the mechanism of 
this mutual inhibition. Small-angle X-ray scattering (SAXS) complemented with hydrogen-deuterium 
exchange mass spectrometry (HDX-MS) data allowed us to obtain 3D structural models comprising 
a trimeric dUTPase complexed with separate Stl monomers. These models thus reveal that upon 
dUTPase-Stl complex formation the functional homodimer of Stl repressor dissociates, which abolishes 
the DNA binding ability of the protein. Active site forming dUTPase segments were directly identified 
to be involved in the dUTPase-Stl interaction by HDX-MS, explaining the loss of dUTPase activity 
upon complexation. Our results provide key novel structural insights that pave the way for further 
applications of the first potent proteinaceous inhibitor of human dUTPase.
Fine-tuned regulation of nucleotide metabolism to ensure DNA replication with high fidelity is essential for 
proper development in all free-living organisms1–8. Imbalanced nucleotide pools leading to genomic instability 
have been implicated in numerous human diseases, e.g. neoplastic and neuronal pathogenesis9–11. Hence, dNTP 
pool sanitizing enzymes have gained much recent interest in biomedical research4,5,12–16.
Deoxyuridine triphosphate nucleotidohydrolase (dUTPase, E.C. 3.6.1.23) catalyzes the hydrolysis of dUTP to 
dUMP and pyrophosphate providing substrate for thymidylate synthase and eliminating dUTP from the DNA 
biosynthetic pathway1,17–19. Deficiency or impaired enzymatic activity of dUTPase leads to the elevation of the 
intracellular dUTP pool and can lead to enhanced uracil incorporation into the DNA20,21. If high genomic ura-
cil content overloads the base-excision repair capacity it will result in DNA fragmentation and subsequent cell 
death19,20,22–25. Proper dUTPase function is thus of key importance in preventing DNA uracilation and hence, in 
preserving genome integrity.
Uracil misincorporation is also a mechanism of cytotoxicity induced by chemotherapeutic agents which tar-
get thymidylate synthase in the treatment of different tumors15,26. This approach has been extensively applied in 
the past few decades, however, with a notable limitation of prevalent drug resistance resulting in a high treat-
ment failure rate27. dUTPase overexpression has been shown to be an important mediator of sensitivity to thy-
midylate synthase targeting agents in various cancer cell lines and tumor specimens and to modulate treatment 
outcome9,10,27–31. These facts underline the significance of dUTPase inhibitory studies to better understand the 
role dUTPase plays in the process of cell death and characterize this enzyme as a promising additional target 
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for anti-cancer drug development in combination therapies with thymidylate synthase inhibitors32. Accordingly, 
numerous studies provide evidence that siRNA-based silencing5 or small molecule (TAS-114) inhibition33 of the 
human dUTPase induces synthetic lethality with fluoropyrimidine (FUdR, 5-FU) and antifolate (pemetrexed) 
treatments in HeLa, CRC, NSCLC cell line models and enhances the anti-tumor effect of therapeutic drugs in 
mouse breast cancer (MX-1) xenografts15.
In addition to small molecular inhibitors, proteinaceous inhibitors present a promising alternative for block-
ing enzyme function with increased selectivity and, consequently, with less intracellular off-target effects. Such 
protein inhibitors also allow specific disruption of cellular DNA repair pathways, facilitating in cellulo studies on 
the effect of enzyme inhibition. A prominent example is presented by the uracil-DNA glycosylase inhibitor (UGI) 
that binds to and blocks the activity of the major uracil-DNA glycosylase enzyme (UNG)34,35. UGI has been first 
isolated from the bacteriophage PBS2 and it has also been successfully used to provide potent inhibitor against 
UNGs from various sources, including the human enzyme34–38.
In a similar approach, recent identification of a novel kind of bacteriophage dUTPase inhibitor protein envi-
sioned additional key opportunities for pathway-specific perturbation of thymidylate biosynthesis. Namely, 
StlSaPIBov1 (Stl), a pathogenicity island (SaPI) repressor protein in Staphylococcus aureus, has been shown to 
interact with the Φ11, 80α and ϕNM1 helper phage dUTPases29,39. This interaction results in the disruption of 
Stl-DNA complex which allows the transcription of the repressed PI genes and the excision and replication of the 
SaPI40,41. Remarkably, the catalytic activity of Φ11 dUTPase (Φ11DUT) is also inhibited upon complex formation 
with Stl, due to the competition of Stl and the substrate dUTP for dUTPase binding revealed by transient kinetic 
analysis42. Moreover, in our recent studies we have also demonstrated that Stl acts as a potent inhibitor of the 
Mycobacterial dUTPase, both in vitro and in vivo21 and exerts inhibitory effect on the Drosophila melanoglaster 
dUTPase in vitro43.
In the present study, we investigated the potential of Stl to act as an inhibitor of the human dUTPase (hDUT) 
using various biochemical and biophysical methods. We found that Stl forms a tight complex with hDUT in vitro 
which results in a strong inhibition of hDUT enzymatic activity. Based on these results we propose that Stl may 
be considered as a potent cross-species protein inhibitor of the human dUTPase enzyme. Understanding the 
molecular mechanism of Stl action on dUTPase might constitute the first step towards the design of an efficient 
and selective proteinaceous inhibitor.
Towards this end, here we present detailed structural insights on this protein-protein interaction with an 
integrated structural biology approach, based on a cutting-edge combination of ITC, native mass spectrome-
try, and most prominently size-exclusion chromatography in line with small-angle X-ray scattering (SEC-SAXS) 
and hydrogen-deuterium exchange mass spectrometry (HDX-MS). While SAXS has already been at the fore-
front of structural biology when applied to complexes that fail to crystallize, structure-related information from 
HDX-MS has only recently been exploited44,45. Recent examples show that combination of the increasingly pow-
erful HDX-MS and SEC-SAXS techniques substantiate advanced 3D models46. The structural insights provided 
by the present work may serve as the first step towards the design of an efficient and selective proteinaceous 
inhibitor of the human dUTPase which can be applied as a cellular tool for in vivo focusing on the physiological 
function of dUTPase.
Materials and Methods
Materials for electrophoresis or chromatography were from BioRad or Amersham Biosciences, molecular biology 
products were from New England Biolabs or Fermentas. Other materials were from Merck KGaA, if not indicated 
otherwise.
Protein expression and purification. Proteins in this study were expressed in E. coli BL21 (DE3) Rosetta 
cells with 0.5 l LB medium and being induced by 0.5 mM isopropyl β-D-1-thiogalactopyranoside IPTG at 
OD600 = 0.6. Stl (orf 20 of SaPIbov1, GI: 11094374) was expressed from a pGEX-4T-1 vector42 (see Supporting 
information), for 4 h at 30 °C. The nuclear isoform of human dUTPase was expressed from a pET15b vector47 for 
4 h at 37 °C. Finally, cells were harvested by centrifugation and stored at −80 °C.
Purification of Stl and hDUT was performed as described previously22,42 (see Supporting information). All 
protein preparations were at least 95% pure as judged by SDS–PAGE. Concentration of proteins were measured 
by a NanoDrop 2000 UV-Vis spectrophotometer using the 280 nm extinction coefficient 35760 M−1 cm−1 and 
10430 M−1 cm−1 for Stl and hDUT respectively, calculated based on amino acid composition (http://web.expasy.
org/protparam). All protein concentrations throughout this study correspond to protomers.
Native gel electrophoresis. Native polyacrylamide gel electrophoresis was performed using 8% poly-
acrylamide gels as described previously42. Briefly, after 1 h of pre-electrophoresis at 100 V, 25 μl of pre-mixed 
samples were loaded on the gel and electrophoresis was done for 5 h at 150 V in Tris-HCl buffer (pH 8.5). The 
apparatus was chilled on ice to avoid heat-induced denaturation. The gel was stained with Coomassie-Brilliant 
Blue dye.
Isothermal titration calorimetry (ITC). ITC experiments were carried out at 20 °C on a Microcal ITC200 
instrument (Malvern Instruments, Malvern, UK). Prior to the measurements hDUT and Stl samples were dia-
lyzed overnight at 4 °C in a buffer of 20 mM HEPES (pH 7.5), 300 mM NaCl, 5 mM MgCl2, 1 mM TCEP. In 
the experimental setup, the cell of the instrument was filled with Stl and the syringe with hDUT. The titrations 
were performed with the injection syringe rotating at 750 r.p.m. and included a series of 20 injections spaced 
180 s apart from each other with injection volumes of 0.5 μl for the first titration and 2 μl for the subsequent 19 
titrations. The apparent dilution heat observed at the end of the titration was subtracted from the integrated 
heat data. The corrected data were then analyzed using MicroCal ORIGIN 7.5 software, following the directions 
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of the manufacturer, in order to determine the dissociation constant (Kd), stoichiometry (N), enthalpy (ΔH) 
and entropy (ΔS). The best fit to the data was obtained using the one set of independent sites binding model of 
the software. Average and standard deviation (SD) of the fitted parameters were calculated from three parallel 
measurements.
Electrospray ionization mass spectrometry. The protein complexes were studied using an unmodified 
commercial Waters QTOF Premier mass spectrometer (Waters, Milford, MA, USA) equipped with electrospray 
ionization source (Waters, Milford, MA, USA) operated in positive ion mode. Mass spectra were obtained under 
native conditions: namely, the ions were generated from aqueous 5 mM NH4HCO3 buffer solution (pH 7.5) con-
taining the human dUTPase, Stl or both protein constructs at ca. 0.5 µM monomer concentration. These condi-
tions are favorable for the transfer of the protein complexes from solution into the gas phase. The capillary voltage 
was 2800 V, the sampling cone voltage was 125 V and the temperature of the source was kept at 80 °C, collision 
cell pressure was 3.43*10−3 mbar and ion guide gas flow was 35.00 ml/min. Mass spectra were recorded using the 
software MassLynx 4.1 (Waters, Milford, MA, USA) in the 1000–8000 m/z mass range.
dUTPase activity assay. Proton release during the hydrolysis of dUTP into dUMP and PPi was followed 
continuously at 559 nm at 20 °C using a Specord 200 spectrophotometer (Analytic Jena, Germany) and 10 mm 
path length thermostatted cuvettes as described previously21,42,48. Reaction mixtures contained 50 nM hDUT 
enzyme and varying concentrations of Stl in activity buffer (1 mM HEPES (pH 7.5), 5 mM MgCl2, 150 mM KCl, 
40 μM Phenol Red indicator). The reaction started with the addition of 30 μM dUTP after 5 min pre-incubation of 
the two proteins in the assay buffer. Initial velocity was determined from the slope of the first 10% of the progress 
curve. Stl inhibition data were fitted to the quadratic binding equation describing 1:1 stoichiometry for the disso-
ciation equilibrium with no cooperativity42.
Electrophoretic mobility shift assay (EMSA). EMSA experiments were performed to test the effect of 
hDUT addition on the interaction of StlSaPIBov1 to its predicted DNA binding site within S. aureus49. For this a 
43 bp double stranded oligonucleotide (previously named as interR) was used49. This oligonucleotide contains 
the symmetric Stl DNA binding site located in the intergenic region between the stl and the str genes. The two 
strands of this oligonucleotide (5′-ATGTTGAAATAAATATCTCGATGTGAGATAATTTGTTCGAGGA-3′ 
and 5′-TCCTCGAACAAATTATCTCACATCGAGATATTTATTTCAACAT-3′) were custom synthesized by 
Eurofins MWG Operon and hybridized by controlled gradual cooling after 5 min incubation on 95 °C. Proteins 
were mixed with 100 ng DNA in 20 μl total volume (NaCl concentration 100 mM in all samples). After 15 min 
incubation at 4 °C, samples were loaded onto a polyacrylamide gel (8%). Electrophoresis was performed in 
Tris-Borate-EDTA (TBE) buffer for 70 min at room temperature (150 V), following 1 h pre-electrophoresis of the 
gel (100 V). Bands were detected with an Uvi-Tec gel documentation system (Cleaver Scientific Ltd., Ruby, UK) 
after staining with GelRed (Bioticum).
Hydrogen deuterium exchange mass spectrometry (HDX-MS). HDX-MS experiments were per-
formed on a Synapt G2Si HDMS coupled to an Acquity UPLC M-Class system with HDX and automation 
(Waters Corporation, Manchester, UK). The isotope uptake of the human dUTPase and Stl proteins was deter-
mined using a continuous labelling workflow at 20 °C. Briefly, each protein was dissolved in buffer E (20 mM 
HEPES, 300 mM NaCl, 5 mM MgCl2, pH 7.5) to a final concentration of 10–20 µM. Isotope labelling was initiated 
by diluting 5 μl of each protein into 95 μl of buffer L (20 mM HEPES, 300 mM NaCl, 5 mM MgCl2 in D2O, pD 7.1). 
Samples were quenched in ice cold buffer Q (2.4% formic acid) after various incubation times then being digested 
online with a Waters Enzymate BEH pepsin column at 20 °C. The peptides were trapped on a Waters BEH C18 
VanGuard pre-column for 3 minutes at a flow rate of 200 μl/min in buffer A (0.1% formic acid ~pH 2.5) and then 
applied to a Waters BEH C-18 analytical column. Peptides were eluted with a linear gradient of buffer B (0.1% 
formic acid in acetonitrile ~pH 2.5) at a flowrate of 40 μl/min. All trapping and chromatography was performed 
at 0.5 °C to minimize back exchange. Characterization of the bound HDX behavior of each protein was carried 
out by premixing the proteins at equimolar concentrations. MS data were acquired using an MSE workflow in 
HD mode with extended range enabled to reduce detector saturation and maintain peak shapes. 6 reference 
acquisitions were obtained for each protein along with labelling acquisitions of 1, 10 and 100 minutes which were 
obtained in triplicate. The MS was calibrated separately against NaI and the MS data were acquired with lock mass 
correction using Leu-enkephalin.
Peptides were assigned with the ProteinLynx Global Server (PLGS, Waters Corporation, Manchester, UK) 
software and the isotope uptake of each peptide was determined with DynamX v3.0. Evaluation of data fitting and 
error of each dataset were performed as described previously50. The total mass shift of each peptide was then plot-
ted against the residue position to generate Woods plots showing the Δmass of each peptide in the bound state51. 
The average mass shift across all peptides at each residue was then calculated and any values that exceed the 95% 
confidence bands for any residue were noted and defined as interaction surfaces of the two proteins. Difference 
plots (Δmass) were prepared for each protein by subtraction of the bound from the unbound HDX-MS patterns 
of each protein. We assumed that all subunits were involved in the protein-protein interactions such that the 
interacting surfaces were projected equally across all subunits.
Small angle X-ray scattering. SAXS measurements. Synchrotron radiation X-ray scattering data were 
collected on the EMBL P12 beamline of the storage ring PETRA III (DESY, Hamburg) (Tables 1 and 2), using 
a PILATUS 2 M pixel detector (DECTRIS, Switzerland). For batch experiments of hDUT and Stl, samples were 
measured in buffer B (50 mM HEPES, pH = 7.5, 300 mM NaCl, 5 mM MgCl2) while flowing through a temper-
ature controlled capillary (1.2 mm I.D.) at 20 °C and 20 frames of 0.05 s exposure time were collected. hDUT:Stl 
complexes (100 µL at ~8 mg/ml) were injected onto a GE Healthcare S200 Increase 10/300 (24 ml) column 
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equilibrated in buffer B and in-line SEC-SAXS performed at a flow rate of 0.5 ml/min. A total of 3600 × 1 second 
SAXS data frames were recorded during elution.
The sample-to-detector distance was 3.1 m, covering a range of momentum transfer 0.01 Å−1 ≤ s ≥ 0.46 Å−1 
(s = 4πsinθ/ λ, where 2θ is the scattering angle, and λ = 1.24 Å is the X-ray wavelength). Based on comparison of 
successive frames, no detectable radiation damage was observed. Data from the detector were normalized to the 
transmitted beam intensity, averaged, placed on absolute scale relative to water and the scattering of buffer solu-
tions subtracted. All data manipulations were performed using PRIMUSqt and the ATSAS software package52. 
SEC-SAXS data were analyzed using CHROMIXS53.
The forward scattering I(0) and radius of gyration, Rg were determined from Guinier analysis54 assuming that 
at very small angles (s ≤ 1.3/Rg) the intensity is represented as I(s) = I(0)exp(−(sRg)2/3)). These parameters were 
also estimated from the full scattering curves using the indirect Fourier transform method implemented in the 
program GNOM55, along with the distance distribution function p(r) and the maximum particle dimensions 
Dmax. Molecular masses (MMs) of solutes were estimated from SAXS data by comparing the extrapolated forward 
scattering with that of a reference solution of bovine serum albumin (Merck KGaA, Darmstadt, Germany), the 
hydrated-particle/Porod volume Vp, where molecular mass is estimated as 0.588 times Vp, and from the excluded 
solvent volumes, Vex obtained from ab initio modeling in the program DAMMIF56. MMs from in-line SEC-SAXS 
data were also estimated using the DATMOW57 routine implemented in ATSAS. Computation of theoretical 
scattering intensities was performed using the program CRYSOL58.
Ab initio shape determination. Low resolution shapes were reconstructed from SAXS data using the programs 
DAMMIF56, which represents the macromolecule as a densely packed interconnected configuration of beads or 
chain-like ensemble of dummy residues, respectively, that best fits the experimental data Iexp(s) by minimizing 
hDUT Stl
Data collection parameters
Instrument EMBL P12 beam line (PETRA-III, DESY, Hamburg)
Beam geometry 0.2 × 0.12 mm2
Wavelength (Å) 1.24
s range (Å−1)a 0.01–0.46
Exposure time (s) 1 (20 × 0.05 s)
Concentration range (mg/mL) 0.2–2.0 0.2–0.9
Temperature (K) 283 283
Structural parametersb
I(0) (cm−1) [from p(r)] 0.025 ± 0.001 0.032 ± 0.001
Rg (Å) [from p(r)] 29 ± 1 32 ± 1
I(0) (cm−1) (from Guinier) 0.025 ± 0.001 0.031 ± 0.001
Rg (Å) (from Guinier) 30 ± 1 33 ± 1
Dmax (Å) 100 105
Porod volume estimate (Å3) 117000 ± 10000 100000 ± 20000
Excluded volume estimate (Å3) 132000 ± 20000 90000 ± 20000
Dry volume calculated from sequence (Å3)c 21815 38738
Molecular-mass determination
I(0) (cm−1) BSA (70,000 Da) 0.050 ± 0.001
Molecular mass Mr (Da) [from I(0)] 35000 ± 4000 45000 ± 5000
Molecular mass Mr (Da) [from Porod volume (Vp/1.6)] 73000 ± 8000 59000 ± 6000
Molecular mass Mr (Da) [from excluded volume (Vex/2)] 66500 ± 10000 45000 ± 5000
Calculated monomeric Mr from sequence (Da) 18029 32015
Software employed
Primary data reduction RADAVER
Data processing PRIMUS/Qt
Ab initio analysis DAMMIF
Validation and averaging DAMAVER
Hybrid modeling CORAL, EOM
Computation of model intensities CRYSOL
3D graphics representations PyMOL, UCSF Chimera
Table 1. SAXS Data collection and derived parameters for hDUT and Stl. Abbreviations: Mr: molecular mass; 
Rg: radius of gyration; Dmax: maximal particle dimension; Vp: Porod volume; Vex: Particle excluded volume. 
aMomentum transfer s = 4πsin(θ)/λ. bValues reported for merged data sets (0.2 & 2.0, and 0.2 & 0.9 mg.mL−1 
for hDUT and Stl, respectively). cDry volume determined using the server: http://www.basic.northwestern.edu/
biotools/proteincalc.html.
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the discrepancy according to equation (1), where N is the number of experimental points, c is a scaling factor and 
Icalc(sj) and σ(sj) are the calculated intensity and the experimental error at the momentum transfer sj, respectively.
∑χ σ= −





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1
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For both 3:3 and 3:2 hDUT:Stl complex data models were generated initially without symmetry (P1) and 
then enforcing P3 (3:3) or P2 (3:2). The symmetry constrained models were checked to be consistent with the 
P1 reconstructions through superposition in SUPALM59. As a quantification of the reliability of models, we con-
sidered effective resolution determined by the recently published Fourier shell correlation (FSC) approach60 and 
normalized spatial discrepancy61 (NSD) values, which represent the measure of the real-space variation of the 
models. Ideal superposition of two compact and rigid structures with the same low resolution shapes gives NSD 
around 1. For the models containing flexible regions of significant length, e.g. flexible N/C termini like in the 
reported case, can still be considered similar in the overall shape if NSD <3.
Molecular Modeling. Human dUTPase crystal structures (PDB IDs are 1Q5U62 and 3EHW) were used as tem-
plates for modeling of the trimeric core of hDUT:Stl complexes. Rigid bodies of Stl were generated applying the 
protein structure prediction server Phyre263 and dimer models from that were created by M-ZDOCK server64 
using C-terminal region (T100-N280) of the Stl model as the dimer interface based on our chemical crosslinking 
results (Supplementary Fig. 3). An additional assessment of Stl protein flexibility based on a dimeric assembly 
determined using EOM59, where a genetic algorithm is used to select an ensemble of best fitting configurations 
from a randomly generated pool. The program CORAL52 was used to perform a multi-step rigid body refinement 
of hDUT and hDUT:Stl complexes in both 3:3 and 3:2 stoichiometries, where a simulated annealing (SA) based 
hDUT:Stl (Region 1) hDUT:Stl (Region 2)
Data collection parameters
 Instrument EMBL P12 beam line (PETRA-III, DESY, Hamburg)
 Beam geometry 0.2 × 0.12 mm2
 Wavelength (Å) 1.24
 s range (Å−1)a 0.01–0.46
 Exposure time (s) 3600 (3600 × 1.0 s)
 Concentration range (mg/mL) ~0.4 ~0.4
 Temperature (K) 283 283
Structural parametersb
 I(0) (cm−1) [from p(r)] 0.041 ± 0.001 0.047 ± 0.001
 Rg (Å) [from p(r)] 45 ± 1 39 ± 1
 I(0) (cm−1) (from Guinier) 0.041 ± 0.001 0.046 ± 0.001
 Rg (Å) (from Guinier) 44 ± 1 38 ± 1
 Dmax (Å) 170 140
 Porod volume estimate (Å3) 227000 ± 10000 190000 ± 20000
 Excluded volume estimate (Å3) 290000 ± 2000 242000 ± 20000
 Dry volume calculated from sequence (Å3)c 188384/149667 (3:3/3:2 complex)
Molecular-mass determination
 I(0) (cm−1) BSA (70,000 Da) 0.050 ± 0.001
 Molecular mass Mr (Da) [from DATMOW] 130000 ± 4000 124000 ± 5000
 Molecular mass Mr (Da) [from Porod volume (Vp/1.6)] 134000 ± 9000 112000 ± 6000
 Molecular mass Mr (Da) [from excluded volume (Vex/2)] 145000 ± 10000 121000 ± 3000
 Calculated monomeric Mr from sequence (Da) 155689/123692 (3:3/3:2 complex)
Software employed
 Primary data reduction RADAVER
 Data processing PRIMUS/Qt
 Ab initio analysis DAMMIF
 Validation and averaging DAMAVER
 Hybrid modeling CORAL
 Computation of model intensities CRYSOL
 3D graphics representations PyMOL, UCSF Chimera
Table 2. SAXS Data collection and derived parameters for hDUT:Stl SEC-SAXS. Abbreviations: Mr: molecular 
mass; Rg: radius of gyration; Dmax: maximal particle dimension; Vp: Porod volume; Vex: Particle excluded 
volume. aMomentum transfer s = 4πsin(θ)/λ. bValues reported for selected buffer corrected SEC-SAXS frames. 
cDry volume determined using the server: http://www.basic.northwestern.edu/biotools/proteincalc.html.
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search of subunit arrangements and orientations, stoichiometry and conformations of missing terminal loops was 
conducted to fit the experimental SAXS data. In the first step, using the SEC-SAXS region 1 data, the position of 
the hDUT trimer was fixed and ambiguous distance restraints (10 Å) based on the potential contacts identified by 
hydrogen deuterium exchange mass spectrometry (HDX-MS) defined between each hDUT (residues A37–R44 
and L88–H92) and Stl monomer (residues Y98-Y113). For hDUT the interfacial residues identified by HDX-MS 
were filtered by surface accessibility (cut-off > 10 Å2) based on the crystal structure (1Q5U) from the regions with 
negative HDX signals (H34–L50 and L88–G110). Refinement was conducted in CORAL applying P3 symmetry 
to generate a symmetric complex with 3:3 hDUT:Stl stoichiometry and to add missing terminal residues and to 
allow a flexible linker between the N and C-terminal domains of Stl. To generate a 3:2 hDUT:Stl complex, sub-
sequent refinement was performed in CORAL against the major SEC-SAXS peak data (region 2) using the rigid 
body model of the 3:3 complex as input with one Stl monomer removed and the hDUT:Stl interface fixed.
For modeling based on SAXS data, multiple runs were performed to verify the stability of the solution, and to 
establish the most typical 3D reconstructions using DAMAVER65. SAXS data has been deposited at the SASBDB 
(www.sasbdb.org) with accession codes: SASDC57, SASDC67, SASDC77, SASDC87.
Results
hDUT-Stl complex formation was verified by independent biophysical methods. To test whether 
Stl may bind to human dUTPase, we first carried out native polyacrylamide gel electrophoresis (Fig. 1a). We run 
samples of individual proteins (Fig. 1a, Lanes 1 and 5) and mixtures of the two proteins of 0.5:1, 1:1, 1.5:1 hDUT:Stl 
molar ratios (Fig. 1a, Lanes 2–4, respectively). Upon mixing of Stl (grey arrowhead) with increasing concentration 
of hDUT (white arrowhead) in the samples, a distinct additional band (black arrowhead) appeared in parallel with 
the gradual disappearance of the Stl band, arguing for the formation a stable hDUT:Stl complex (Fig. 1a).
We observed no complex formation when human dUTPase was pre-mixed with 60-fold excess of the slowly 
hydrolyzable substrate analogue dUPNPP (Fig. 1b, Lane 2). Nevertheless, the pre-formed hDUT:Stl complex did 
not dissociate upon the addition of the same amount of this substrate analogue (Fig. 1b, Lane 1). These results 
indicate that Stl is a slow-binding competitor of the substrate analogue, as in the case of Φ11DUT42.
We performed additional experiments to quantitatively analyze this Stl-hDUT interaction. Data from isother-
mal titration calorimetry (ITC) measurements indicated that Stl and hDUT form a considerably strong complex 
with a Kd of 0.23 ± 0.02 µM (Fig. 1c). Note that this apparent affinity is in the same order of magnitude that 
was determined for the Φ11DUT-Stl interaction with ITC42 (cf. Fig. 1c). In addition, thermodynamic analysis 
displayed a similar energetic contribution in case of hDUT-Stl and Φ11DUT-Stl interactions with favorable con-
tribution of binding enthalpy, and, (to a lesser extent) entropy of complexation. The N = 1.27 ± 0.01 stoichiom-
etry formally indicates that 1.27 hDUT protomer forms a complex with 1 Stl protomer (ie. 3 hDUT protomers, 
equivalent to a dUTPase trimer interact with to 2.4 Stl protomers). Taking into account that human dUTPase 
protomers form a stable trimer66–68 and considering that Stl is in monomer-dimer equilibrium42, this 3 to 2.4 
hDUT-Stl protomer ratio could reflect macromolecular complex formation between i) hDUT3Stl2 formed by one 
dUTPase trimer and 2 Stl molecules (1 dimer/ 2 monomers) or ii) hDUT3Stl3 consisting of one hDUT trimer and 
3 Stl molecules (1 dimer + 1 monomer/ 3 monomers) or the mixture of these complexes.
To provide additional experimental evidence for the molecular composition of hDUT:Stl complex, we per-
formed native electrospray ionization mass spectrometry (ESI-MS) analysis. In the native MS spectrum of the 
mixture of the two proteins it was observed that hDUT and Stl form a hetero-oligomer, while peaks of Stl dimer 
are also present in the spectrum (Supplementary Fig. 1). The molecular mass of the complex was found to be 
120.0 ± 0.1 kDa, which corresponds to hDUT3Stl2 a complex of two Stl monomers (65.8 kDa) with a human dUT-
Pase trimer (54.1 kDa). The peaks of the hetero-oligomer showed a Gaussian-like distribution, with the maximum 
at m/z 4622 (26+).
Inhibition of hDUT catalytic activity. Having established that hDUT and Stl form a strong complex, it 
was of immediate interest to analyze whether this complexation has any effect on the cognate physiological func-
tions of either components of the complex. To test whether complexation with Stl might also affect the function 
of the human enzyme, we measured hDUT enzymatic activity in the presence and absence of Stl (Fig. 1d). We 
found that Stl exerted ca. 70% inhibition on human dUTPase catalytic activity (Fig. 1d). Titration experiments 
with varied concentrations of Stl showed that the inhibitory effect of Stl is associated with an apparent inhibitory 
constant (Ki = 6.7 ± 2.4 nM), suggesting that Stl is a highly potent inhibitor of the human dUTPase. Stl inhibition 
was only observed when hDUT was pre-incubated with Stl before the addition of dUTP. This indicates that the 
complex formation between hDUT and Stl is slow as compared to substrate binding, reinforcing the predictions 
of native polyacrylamide gel electrophoresis results with substrate analogue.
Perturbation of Stl-DNA complex formation by the human dUTPase. In Staphylococcus aureus, Stl 
acts as a transcriptional repressor for the pathogenicity island SaPIbov1 and is responsible for blocking the hori-
zontal transfer of this mobile genetic element40,41. We were interested in whether the interaction with hDUT may 
also be able to modulate Stl repressor activity. To assess this question, electrophoretic mobility shift assay (EMSA) 
experiments were performed. DNA containing the validated Stl binding site49 was added to samples containing 
Stl, Stl:hDUT complex or hDUT (Fig. 1e). When only Stl was mixed with DNA, the band of DNA was shifted to 
an upper position of the native polyacrylamide gel because of complex formation (cf. Fig. 1e, Lane 1 and Lane 2). 
As the hDUT concentration was increased in the samples, intensity of the bands of Stl-DNA complex gradually 
decreased, meanwhile the bands of free DNA became more intense. These results present clear evidence that 
complex formation with hDUT inhibited Stl binding to its consensus DNA binding site.
www.nature.com/scientificreports/
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Analysis of the interaction surface of the human dUTPase: Stl complex by hydrogen deu-
terium exchange mass spectrometry. The human dUTPase:Stl interaction was investigated by 
hydrogen-deuterium exchange mass spectrometry (HDX-MS). HDX-MS is a powerful biophysical technique 
that reports on time-dependent changes in the local deuterium uptake of a protein in D2O solvent44. The isotope 
uptake rates are dependent on the environment of exchangeable sites providing structural and dynamical infor-
mation on these protein regions. The isotope uptake of the individual proteins as well as the premixed complex 
were characterized using a continuous labeling strategy recorded at three labelling time points (cf. Methods). The 
resulting HDX-MS patterns recorded for the complex were then subtracted from those obtained for the individ-
ual proteins to yield difference plots for both proteins which provide insight into the change in isotope uptake 
between the individual and assembled proteins (Fig. 2). The sequence coverage excluding tags for Stl and hDUT 
was 94.0% and 95.7%, respectively and the redundancy was over 2 in both cases (Supplementary Fig. 2).
The difference plot generated from the HDX-MS results of human dUTPase in the presence of Stl shows 
a clear negative mass shift that localizes to specific peptide regions (Fig. 2c, peptide numbering is shown on 
Supplementary Fig. 2). In order to understand these changes at the residue level, Woods plots were prepared from 
the HDX-MS difference outputs where the mass shift of each peptide is reported on the primary sequence of the 
protein (See methods)69. The most significant mass shifts of hDUT in the presence of Stl maps to a segment of res-
idues 34H–50L whereas large mass shifts are also observed at the C-terminus of hDUT although these Δmasses 
converge more rapidly implying a weaker interaction in this region (Fig. 2c,d). Peptides 30–41 show modest but 
persistent changes implying the role of residues 89A–110G in the interaction.
The HDX-MS difference plots for Stl in the presence of human dUTPase shows a clear negative mass shift that 
localizes to a narrow band of peptides (Fig. 2e,f). When projected onto the Stl sequence the most significant mass 
shifts are localized for peptides 21–24 corresponding to a segment of residues 98Y–113Y (Fig. 2e,f). In addition 
we observed minor changes in isotope uptake of Stl across the entire length of the protein upon binding to dUT-
Pase. This suggests that Stl may undergo a global decrease in dynamics in the bound state and that although the 
binding is localized to a specific region the interaction is communicated across the entire protein.
Figure 1. Identification and functional analysis of the interaction between the human dUTPase and Stl. (A,B) 
Native gel electrophoresis demonstrates apparence of a band corresponding to hDUT-Stl complex (black 
arrowhead) when mixing Stl (grey arrowhead) and hDUT (white arrowhead) samples. Panel B shows how 
the substrate analogue dUPNPP affects complex formation and the dependence of this effect on the order of 
mixing. (Full-length gel is included in the Supplementary Information.) (C) Equilibrium binding of hDUT to 
Stl assessed by isothermal titration calorimetry (ITC). One representative graph is shown from three parallel 
experiments. Average and SD of parameters determined by fitting a one set of sites model to the integrated 
titration data (N, stoichiometry, Kd, binding affinity, ΔH, binding enthalpy, -TΔS binding entropy, ΔG binding 
free enthalpy) are shown. Parameters determined from one experiment for Φ11DUT:Stl interaction are shown 
alongside, errors in that case represent the reliability of the fitting of one set of sites model on the data42. (D) 
Inhibitory effects of Stl on hDUT catalytic activity (representative measurement). dUTPase enzymatic activity 
was measured in the presence and absence of Stl. The quadratic equation line fitted to the data resulted in the 
apparent Ki = 6.7 ± 2.4 nM. (E) Stl DNA-binding ability is disrupted during complex formation with hDUT, 
verified by electrophoretic mobility shift assay (EMSA).(Full-length gel is included in the Supplementary 
Information.).
www.nature.com/scientificreports/
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SAXS analysis of Stl and human dUTPase complexes. To assess the molecular shapes of hDUT and 
Stl and to determine the solution structure of the hDUT:Stl complex at low-resolution, SAXS experiments were 
performed. Results obtained are represented in Figs 3–5 and Tables 1 and 2. Previous SAXS studies performed 
on full-length hDUT demonstrate that the protein adopts a trimeric arrangement in solution consistent with the 
crystal structure (PDB ID: 1Q5U)62,67. Data obtained for hDUT yielded structural parameters and shapes con-
sistent with single trimeric hDUT (Table 1). SAXS data for Stl suggested that the protein predominantly forms 
dimers in solution (Fig. 4 and Table 1), which is consistent with the dimer formation observed by native mass 
spectrometry and chemical crosslinking42 (Supplementary Figs 1 and 3). The ab initio models of the Stl dimer 
have an effective resolution of 4.9 ± 0.4 nm and average NSD of 1.5 ± 0.4. As no 3D structural information cur-
rently exists for Stl, structural models were generated using the Phyre2 server, validated by synchrotron radiation 
circular dichroism measurements70 and screened against the experimental SAXS data. A dimeric assembly of 
the best Phyre2 model was found to provide an excellent fit (χ2 = 1.0 between the model and experimental data) 
(Fig. 3a), which indicates that this is a valid model of the average structure in solution. This dimeric model was 
subsequently used for SAXS modeling procedures.
The observed relatively low resolution of the ab initio models for the Stl dimer suggests flexible nature of the 
protein. Thus the flexibility of the Stl dimer was investigated using an ensemble based approach, where based on 
chemical crosslinking results (Supplementary Fig. 3) the dimer interface was formed by the C-terminal region 
Figure 2. Representation of the hydrogen-deuterium exchange mass spectrometry results. (A,B) Sequence of 
human dUTPase and Stl proteins, respectively. Numbering starts at the first residue of the Uniprot sequences of 
the proteins (Uniprot IDs: P33316-2 and Q9F0J8 respectively). Extension compared to Uniprot sequence is in 
italics. Active site residues in case of dUTPase and the DNA binding motif of Stl are boxed. Sequence is colored 
according to HDX data (Δmass accumulated across all labelling times) applying color-scheme displayed on 
Panel G. (C–F) HDX-MS difference data (C and E) and associate Woods plots (D and F) for hDUT (C,D) and 
Stl (E,F) showing the change in isotope uptake upon complexation of the proteins. Labelling time points are 
indicated by different colors and the dashed lines in Panels C and E represent the 95% confidence bands. (G) 
Representation of the HDX-MS difference data on the surface of the human dUTPase and Stl. In case of the 
human dUTPase an apo state structure is shown (PDB ID: 1Q5U), the C-terminal 13 residues are omitted from 
the representation since the position of these residues were not resolved in the crystal structure presumably 
because of flexibility. Position of the substrate analogue is shown based on the structural alignment of the apo 
and ligand-bound structures (3EHW). The substrate analogue is shown as spheres with elemental coloring 
(carbon white, nitrogen blue, oxygen red, phosphorus orange) to visualize the interference of Stl and substrate 
binding. In case of Stl a Phyre2 generated model is shown, which was compatible with synchrotron radiation 
circular dichroism and mutagenesis results obtained for the protein. Coloring is according to the scale at the 
bottom of the panel.
www.nature.com/scientificreports/
9SciEnTiFic RePoRTS |  (2018) 8:4326  | DOI:10.1038/s41598-018-22145-8
(T87-N267) of the Stl model and was fixed while random configurations of the N-terminal region (M1-K83) 
were generated. The results of this procedure are represented in size-distributions calculated from the pool and 
the selected ensemble of best-fitting configurations, with both distributions appearing to be similarly broad thus 
supporting a highly flexible domain arrangement of Stl protein (Fig. 4b). Domain flexibility in a dynamic system 
involving Stl-DNA interactions and modulation of that by Stl:hDUT complexation may be functionally impor-
tant, so this was taken into account for subsequent hybrid modelling procedures.
To evaluate the formation of hDUT:Stl complexes and determine probable stoichiometry and 
three-dimensional structures, in-line SEC-SAXS experiments were conducted. A single peak with a small leading 
edge was observed (Supplementary Fig. 4), and individual scattering frames were examined across this peak. The 
SAXS parameters extracted from these frames show two self-consistent regions, with correlation map analysis71 
identifying two pools of similar frames referred to as region 1 and region 2 (Table 2, Supplementary Fig. 4). 
The molecular weight parameters of region 1 and region 2 are consistent with 3:3 and 3:2 hDUT:Stl complexes, 
respectively, which were expected based on ITC and ESI-MS data. The existence of two type of complexes is 
also suggested by the higher Rg and Dmax of region 1 compared to region 2 (45 Å and 170 Å vs 39 Å and 140 Å, 
respectively). The real-space distance distribution functions, P(r) for both SEC-SAXS regions are characteristic 
of extended structures, with the region 1 data clearly more extended than that of region 2 (Fig. 3c). Ab initio 
shape reconstructions for the region 1 and region 2 peak data yielded models that are clearly consistent with that 
expected for heterohexameric and heteropentameric hDUT:Stl assemblies (Fig. 5). The effective resolution is 
estimated at 3.7 ± 0.3 nm and 5.3 ± 0.4 nm for the 3:3 and 3:2 models, respectively.
Both reconstructions can easily accommodate a trimeric hDUT core with the remaining volume occupied 
by three or two Stl monomers, respectively. Interestingly, no reasonable solutions for the complexes could be 
obtained using a dimeric Stl model, suggesting that disruption of the Stl dimer is inevitable for the formation of 
this complex. Encouraged by the ab initio modeling results, rigid body structure calculations were conducted 
using the SAXS data and constraints based on HDX-MS using the trimeric hDUT core and Stl monomers taken 
from the Phyre2 homology model. The top 20 models obtained for hDUT3Stl3 were clustered based on the relative 
position of the N-terminal (residues 1–84, StlN) and C-terminal (residues 85–267, StlC) segments of Stl to the 
dUTPase substrate binding pocket (Supplementary Table S1). HDX-MS data shown here and our former experi-
ments70 showed that StlC directly interacts the dUTPase, while StlN has a limited contribution. It is important to 
note that the models showing the best χ2 statistics were also the ones satisfying these criteria (cf. models 11 and 
Figure 3. SAXS data for hDUT, Stl and complexes. (A) SAXS data (circles) and model fits (ab initio–dotted lines, 
rigid body models/RBM–solid lines) for human dUTPase (hDUT), Stl and hDUT:Stl complexes. The hDUT:Stl 
data shown corresponds to SEC-SAXS peak region 1 (green circles) and peak region 2 (dark blue circles). (B) 
Guinier plots of data in Panel A showing linearity of data at low angles, (C) Real-space pair distance distribution 
functions corresponding to an indirect Fourier transformation of the SAXS data in Panel A, showing the clear 
increase in maximum particle dimension upon interaction between the human dUTPase and Stl.
www.nature.com/scientificreports/
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17, in Cluster 1 in Supplementary Table S1). A representative model is shown on Fig. 5 (model 11, χ2 = 1.4, Fig. 
3a). The best model hDUT3Stl2 matching with this quaternary structure (Fig. 5) had also a good agreement with 
the SAXS data (χ2 = 1.2, Fig. 3a). These models also correspond well with the HDX-MS results as most of the 
Figure 5. Models generated based on SEC-SAXS measurements for hDUT:Stl complex. Overlay of the 
SAXS/HDX-MS hybrid models of the hDUT3Stl3 (A) and hDUT3Stl2 (B) complexes and the ab initio shape 
envelopes reconstructed from SAXS data. The hDUT monomers are shown as red, yellow and blue cartoons. Stl 
monomers are shown as light-blue cartoons. Regions of missing sequence added during modeling as dummy 
residues are shown in wire format.
Figure 4. Models generated based on SAXS measurements for Stl. (A) Overlay of the dimeric Stl model from 
the Phyre2 server and the ab initio shape envelope reconstructed from SAXS data. StlN designates the amino 
terminal segment while StlC denotes the carboxy terminal segment of Stl according to ref.67. (B) Rg size-
distribution from ensemble analysis of Stl SAXS data with EOM, showing the high level of flexibility of the 
selected ensemble relative to that of the random pool. The flexibility metric Rflex is 88% for both the selected 
ensemble and the initial pool, reflecting the presence of inter-domain flexibility while maintaining the dimeric 
interface.
www.nature.com/scientificreports/
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dUTPase and Stl surface which showed negative HDX-MS signal, is buried in the complex (cf. Supplementary 
Fig. 5 and 6). Note that the HDX-MS results are referring to data obtained for tryptic peptide fragments, so it is 
possible that not all residues in a peptide are uniformly responsible for the signal, and involved in protein-protein 
interaction. Although more detailed information about the role of individual residues could only be assessed by 
extensive mutagenesis study of this complex, which is beyond the scope of this study.
Discussion
Previous studies have provided evidence that the staphylococcal repressor protein Stl can form a complex with 
the trimeric dUTPases from S. aureus Φ11 and 80α phages, M. tuberculosis, and D. melanogaster in vitro21,42,43, 
although the latter two proteins share only modest sequence similarity with the original phage dUTPase partners 
of Stl. Using various techniques we have now demonstrated that Stl also interacts with the human dUTPase, 
which displays 62% sequence similarity to the phage dUTPases (Supplementary Fig. 7). Table 3 shows the data 
available to date on complexation of Stl and dUTPases from various sources.
We have shown that the Stl-dUTPase interaction has strong functional consequences with regard to the bio-
logical function of both proteins in the complex (cf. Table 3). Namely, complexation inhibits both i) enzymatic 
activity of dUTPase, and ii) DNA-binding capability of the Stl repressor.
To understand the mechanism of these dual inhibitory effects, detailed biophysical and structural informa-
tion about the complex is indispensable. Here we exhibit such hitherto unseen insights applying cross platform 
approach, by combining ITC, mass spectrometry, SEC-SAXS and HDX-MS results to analyze the complex of 
human dUTPase with Stl. Our results presented herein argue altogether for the formation of hDUT3Stl2 and 
hDUT3Stl3 complexes. The 3:2 stoichiometry was also suggested for the complex of Φ11 phage and D. melano-
gaster dUTPases with Stl based on native MS42,43. It is important also to note that a higher order complex with Stl 
was suggested to exist for Φ11 phage dUTPase based on native gel electrophoresis results42.
Kinetic analysis revealed a slow and tight binding interaction between Stl and Φ11DUT where Stl and dUTP 
competes for the active site of the dUTPase42. We observed drastic dependence of human dUTPase inhibition and 
complex formation on the order of mixing of components in case of the kinetic studies and the native gel electro-
phoresis. Since we only observed inhibition or complex formation when Stl was premixed with hDUT, we suggest 
that Stl potentially acts through a slow and tight binding mechanism on the human dUTPase, similarly to that of 
Φ11DUT42. The Stl protein and the substrate dUTP were shown to compete with each other for dUTPase binding 
in case of Φ11DUT42. Our native gel result argues for similar mechanism in case of human dUTPase. Although, 
the maximal inhibitory effect of Stl exerted on Φ11DUT and hDUT differs (ca.100 vs 70% inhibition, respec-
tively), these two dUTPases seem to accommodate Stl in similar ways. However the differences that result in the 
species specific inhibitory effect remains to be explored. In addition to the trimeric dUTPases, Stl also inhibits the 
dUTPase of the ϕNM1 phage39 although this enzyme belongs to the dimeric dUTPase family associated with a 
completely different all-α-helical fold as compared to the beta-pleated trimeric enzymes. It is plausible to suggest 
that the dUTP binding pocket is directly involved in complex formation based on the observed general inhibitory 
effect of Stl on enzymatic activity on differently folded dUTPases.
To reveal the interaction surface of the human dUTPase with Stl, hydrogen deuterium exchange mass spec-
trometry measurements were performed on the individual proteins and the complex. Overall the HDX-MS data 
provide additional and conclusive evidence of a human dUTPase:Stl interaction, moreover these data also reveal 
that the interaction is localized to specific regions of the proteins. In the case of the human dUTPase the most 
significant changes were observed for peptides from the regions covering residues 34H–50L and 89A–110G, 
which overlap with the first three conserved motifs of dUTPases (Fig. 2a). In addition to these segments, H-D 
exchange rates at the carboxy terminal region of the human dUTPase, which includes the fifth conserved motif, 
was also affected by the complex formation. However, fluctuations of the H-D exchange rates point to a weaker 
and transient interaction involving this segment. The three active sites within trimeric dUTPases are all built 
from residues of the five conserved motifs from all the 3 subunits in a specific pattern. Namely, each active site is 
Origin of dUTPase Origin of dUTPase
Characteristics of interaction
In vivo functional effectAffinity (Kd*) dUTPase inhibition
S. aureus 
phages
 Φ11 β-pleated trimer 1.84 nM (BLI
77), 100 nM 
(ITC42) 62 nM (QCM42)
Ki,app = 27 nM42 
Ki,app = 1.2 nM78 ca. 
100% inhibition42,78
induction of SaPIbov1 
transfer in S. aureus40
80α β-pleated trimer 40 nM (BLI77) n.d.# induction of SaPIbov1 transfer in S. aureus40
ϕNM1 all-α helical dimer
qualitatively verified by Ni-
NTA co-elution, crosslink 
SDS-PAGE, EMSA39
activity decrease in 
the presence of Stl39
induction of SaPIbov1 
transfer in S. aureus39
prokaryote M. tuberculosis β-pleated trimer
qualitatively verified by 
native gel electrophoresis21 
EMSA78
max. 84% inhibition 
Ki,app = 5.5 nM21
Stl expression: perturbed 
colony formation and 
increased cellular dUTP 
level in M. smegmatis21
insect Drosphila melanoglaster β-pleated trimer n.d.# max. 40% inhibition Ki,app = 30 nM43
n.d.#
mammal human β-pleated trimer 230 nM (ITC)$ max. 70% inhibition
$ 
Ki,app = 6.7 nM$
n.d.#
Table 3. Summary of the results on dUTPase-Stl interaction. *Where available. #Non-defined. $This work.
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constituted as follows: one subunit donates conserved motifs 1, 2 and 4 and another contributes motif 3 to form 
the substrate binding cavity between two subunits, which is closed by the flexible motif 5 of the third protomer 
upon substrate binding. This closed conformation of motif 5 creates the catalytically competent active site archi-
tecture by providing conserved residues with decisive role in enzyme catalysis72–74. It is apparent that the inter-
action surface of human dUTPase with Stl identified by HDX-MS directly involves the substrate binding pocket 
(Fig. 2g). We also showed that dUTP and Stl binding to dUTPase are mutually exclusive (Fig. 1d and E)21,42, so 
that Stl can only bind to the substrate-free form of dUTPase. In this substrate-free conformation, the conserved 
motif 5 is flexible and the active site is accessible62,67,75,76.
Taken together the HDX-MS and enzyme kinetic data, we suggest a mechanistic model in that Stl is allowed 
to dock into the substrate binding cavity of dUTPase only if access to the cavity is not hindered by either the sub-
strate or the closed conformation of the flexible motif 5. The complex may be further stabilized by interactions 
involving the flexible motif 5 of the human dUTPase and Stl, which is consistent with the observed decrease in 
the H/D exchange rate of the conserved motif 5 upon complex formation. However, this potential additional 
effect possesses transient characteristics according to the HDX-MS data, which is consonant with our previous 
results, that Stl binding was not perturbed in the case of the Φ11DUT mutant lacking motif 542. Although based 
on mutational analysis the contribution of this segment to the protein-protein interaction varies between 80α 
and Φ11 dUTPases, the experimental data for interaction of phage dUTPases with Stl is also in agreement with 
our model77. It is also worth to note that a region including the β-and γ-phosphate coordinating motif 2 showed 
significant decrease in the H/D exchange rate, which is consistent with the previous finding that only dUTP but 
not dUMP perturb the complex formation of dUTPases with Stl42,77.
In the case of Stl, the HDX-MS measurements revealed that a specific Tyr-rich region of the Stl protein (seg-
ment 98Y–113Y) showed significant H/D exchange rate decrease upon addition of dUTPase. This result implies 
that this segment became less solvent accessible, which indicates that it is involved in the interaction with dUT-
Pase (Fig. 2e,f). This finding is consistent with our previous results that removal of the N-terminal segment 
(residues 1–85) of Stl did not perturb the protein-protein interaction70. The global negative HDX data observed 
for the peptides along the whole Stl sequence might correspond to the decrease in the flexibility of the protein 
upon Stl-dUTPase complex formation. We have not observed significant positive HDX signal, which would pre-
sumably be a consequence of the dissociation of the Stl dimer. These experimental data together with previous 
results on dUTPase-Stl interactions reinforce our postulation that the dimer interface of Stl might overlap with 
the Stl-hDUT interaction surface70.
This previous hypothesis is well supported here by the 3D models of the hDUT3Stl3 and hDUT3Stl2 complexes 
generated from the experimental SEC-SAXS data applying HDX-MS results as restraints (cf. Fig. 5). Optimal 
solutions were not obtained in hybrid SAXS modeling with HDX-MS restraints if dimeric Stl was used. Indeed, 
the only models providing excellent agreement with the experimental data were those generated from trimeric 
hDUT and two/three Stl monomers (cf. Fig. 3a and Supplementary Figs 5 and 6). Recently developed strategies 
to simulate HDX-MS difference data for quantitative scoring of docking outputs, may stimulate further refine-
ment studies beyond the scope of this work69. This pioneering 3D model provides an insightful explanation for 
the dUTPase-induced perturbation of DNA-binding by Stl, since Stl is expected to exert its repressor function as 
dimer. We suggest that Stl binding to trimeric dUTPase initiates dissociation of the Stl dimer with concomitant 
perturbation of the Stl-DNA interaction (cf. Fig. 6). Strikingly, a somewhat analogous mechanism was suggested 
for the Stl-dimeric dUTPase interaction, however, in that model both Stl and dUTPase oligomers fall apart to 
form a heterodimer of one Stl and one dUTPase monomer39. It seems that Stl-dUTPase complexation has some 
general characteristics but also show unique traits specific to the actual dUTPase partner (cf. also Table 3). Our 
focused study on the structural requirements of human dUTPase / Stl interaction may therefore serve as the start-
ing point of future development of a species-specific dUTPase inhibitory peptide or protein.
Conclusions
The human dUTPase has a prominent role in guarding genome integrity via removal of dUTP from the nucleotide 
pool, which designates this enzyme as a target for onco-therapies. Accordingly, small molecular drug-candidates 
Figure 6. Schematic model of hDUT:Stl complex assembly and Stl-DNA interaction. According to our 
results human dUTPase is not able bind to Stl and its substrate simultaneously, and is inhibited by Stl. Stl-
DNA complex is also disrupted by hDUT. We showed experimental evidence on the existence of hDUT3Stl3 
and hDUT3Stl2 complexes. The 3D structural models for hDUT:Stl complexes presented here revealed that 
interaction of trimeric dUTPase with Stl leads to disruption of the Stl dimers.
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were developed to inhibit dUTPase function and some of these are currently evaluated in Phase 1 trials33. Here we 
describe the discovery that the staphylococcal Stl repressor is a potent protein inhibitor of human dUTPase and 
as such, it can be used as a versatile tool to decipher the cellular pathways involving dUTPase function. Detailed 
understanding of the molecular mechanism of action of complex formation between human dUTPase and Stl, as 
well as the ensuing functional effects requires in-depth biophysical characterization.
The present results on complexation of human dUTPase:Stl and the obtained structural model based on 
HDX-MS together with an integrated structural biology approach and complex structure provide plausible expla-
nations for mutual inhibition of Stl and dUTPase physiological function in their complex. On one hand, HDX 
results clearly delineated peptide segments around the dUTPase active site that are involved in binding to Stl and 
these data are in line with the observed inhibition of the dUTPase enzymatic function and competition between 
Stl and dUTP for binding to dUTPase. Importantly, the entrance to the dUTP accommodating beta-hairpin (ie 
conserved Motif 3) as well as the interaction surface for beta-gamma phosphate-chain of the substrate (ie con-
served Motif 2) are both identified in our present study as involved in Stl binding. On the other hand, loss of the 
DNA-binding capability of Stl in its complex with human dUTPase is rationalized in light of the model resulting 
from SEC-SAXS measurements that necessarily involves Stl monomers hereby disrupting the functional repressor 
homodimer.
We conclude that proteinaceous inhibition of human dUTPase by Stl offers a novel, promising tool to inves-
tigate dUTPase function in different systems and propose further exploitation of Stl as a dUTPase-specific 
inhibitor. Our evidence-based structural model offers unparalleled insights into the mechanism of Stl-dUTPase 
complexation in general. Additionally, the model clearly delineates the peptide segments of Stl involved in inter-
action of the human enzyme alluding to the possibility of development of peptide based inhibitors. Since dUT-
Pase is a key factor in genome integrity, the potentials of Stl or its derivatives to be used as a specific inhibitor 
cannot be underestimated.
Data Availability Statement. SAXS data is deposited in the Small Angle Scattering Biological Data Bank 
(www.sasbdb.org), with accession codes: SASDC57, SASDC67, SASDC77, SASDC87.
All other data generated or analysed during this study are included in this published article (and its supple-
mentary information files).
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